Xenon Pharmaceuticals Inc header image

Xenon Pharmaceuticals Inc

XENE

Equity

ISIN null / Valor 25419823

NASDAQ (2026-04-30)

USD 56.04+0.52%

Xenon Pharmaceuticals Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Xenon Pharmaceuticals Inc is a biopharmaceutical company dedicated to the discovery and development of novel small molecule therapies targeting neurological and central nervous system disorders. The company focuses on advancing treatments for conditions such as epilepsy and dystonia, utilizing its proprietary drug discovery platforms to move candidates through clinical development stages. Operating primarily in the United States, Canada, and the European Union, Xenon Pharmaceuticals aims to address unmet medical needs by delivering innovative therapeutic solutions within the neurological space.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

46.7%1Y

39.1%3Y

206%5Y

Performance

56.3%1Y

45.8%3Y

57.8%5Y

Volatility

4662 M

Market cap (USD)

1,345,956

Daily traded volume (Shares)

38.78 / 38.23

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

International Flavors & Fragrances Inc

International Flavors & Fragrances Inc Valor: 941876

Annual Return

-50%0%+50%

Risk level

110

0.87%USD 70.81

BrightSpring Health Services Inc

BrightSpring Health Services Inc Valor: 131996976

Annual Return

-50%0%+50%

Risk level

110

-0.37%USD 47.97

Stryker Corp

Stryker Corp Valor: 974330

Annual Return

-50%0%+50%

Risk level

110

-6.47%USD 294.73

Camurus AB

Camurus AB Valor: 30510553

Annual Return

-50%0%+50%

Risk level

110

0.38%SEK 531.00

Medicover AB

Medicover AB Valor: 36765439

Annual Return

-50%0%+50%

Risk level

110

-1.19%SEK 207.50

Arjo AB

Arjo AB Valor: 39115843

Annual Return

-50%0%+50%

Risk level

110

-0.66%SEK 24.24

Xvivo Perfusion AB

Xvivo Perfusion AB Valor: 19661174

Annual Return

-50%0%+50%

Risk level

110

-0.72%SEK 274.40

PTC Therapeutics Inc

PTC Therapeutics Inc Valor: 2515234

Annual Return

-50%0%+50%

Risk level

110

0.79%USD 65.06

Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical Inc Valor: 22860122

Annual Return

-50%0%+50%

Risk level

110

2.11%USD 24.69

Revolution Medicines Inc

Revolution Medicines Inc Valor: 52143299

Annual Return

-50%0%+50%

Risk level

110

2.54%USD 144.12

SIX

FactSet

Clearbit

Logos provided by Clearbit